Cargando…
Intraperitoneal injection of the SIRT1 activator SRT1720 attenuates the progression of experimental osteoarthritis in mice
OBJECTIVES: This study aimed to examine the effects of SRT1720, a potent SIRT1 activator, on osteoarthritis (OA) progression using an experimental OA model. METHODS: Osteoarthritis was surgically induced by destabilization of the medial meniscus in eight-week-old C57BL/6 male mice. SRT1720 was admin...
Autores principales: | Nishida, K., Matsushita, T., Takayama, K., Tanaka, T., Miyaji, N., Ibaraki, K., Araki, D., Kanzaki, N., Matsumoto, T., Kuroda, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987681/ https://www.ncbi.nlm.nih.gov/pubmed/29922443 http://dx.doi.org/10.1302/2046-3758.73.BJR-2017-0227.R1 |
Ejemplares similares
-
SRT2183 and SRT1720, but not Resveratrol, Inhibit Osteoclast Formation and Resorption in the Presence or Absence of Sirt1
por: Thiyagarajan, Ramkumar, et al.
Publicado: (2023) -
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
por: Chao, Chih-Chang, et al.
Publicado: (2022) -
SRT1720 improves survival and healthspan of obese mice
por: Minor, Robin K., et al.
Publicado: (2011) -
CORRIGENDUM: SRT1720 improves survival and healthspan of obese mice
por: Minor, Robin K., et al.
Publicado: (2013) -
SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
por: Yu, Linxi, et al.
Publicado: (2017)